Stock Events

Johnson & Johnson 

$145.65
29340
-$0.38-0.26% Wednesday 19:54

統計

當日最高
146.65
當日最低
144.74
52週最高
170.63
52週最低
141.57
成交量
3,229,576
平均成交量
6,791,417
市值
350.54B
市盈率
9.53
股息收益率
3.41%
股息
4.96

即將到來

股息

3.41%股息收益率
10年增長
5.93%
5年增長率
5.54%
3年增長率
5.43%
1年增長率
4.47%

收益

17Jul確認
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
下一個
2.23
2.42
2.61
2.8
預期每股收益
2.51
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 JNJ 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

179.8$平均價格目標
最高估價為 $215。
來自過去 6 個月內的 5 個評級。這不是投資建議。
買入
60%
持有
40%
賣出
0%

關於

Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Show more...
首席執行官
Alex Gorsky
員工
131900
國家
US
ISIN
US4781601046
WKN
000853260

上市公司